Home › Funds › Alpha Wave Global, LP › AMLX

Alpha Wave Global, LP position in AMLX

AMYLYX PHARMACEUTICALS INC · Health Care

Alpha Wave Global, LP reported holding 155,422 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$2.8M, representing 0.04% of its reported portfolio and ranking #20 among its reported holdings. Alpha Wave Global, LP has disclosed AMLX holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)155.42K sh
Reported value held$2.79M
Portfolio Weight0.04%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Alpha Wave Global, LP's AMLX position evolved

Alpha Wave Global, LP first disclosed a stake in AMLX in Q3 2023 at 853,262 shares (US$15.6M). Across 10 filings, Alpha Wave Global, LP increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 155,422 shares valued at US$2.8M — an increase of 13,086 shares quarter over quarter.. Notable position changes include a 78% trim in Q4 2024 (shares fell 6% over the following quarter), a 47% increase in Q2 2025 (shares rose 112% over the following quarter), a 55% trim in Q1 2026 (shares rose 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 853.26K $15.62M New
Q4 2023 846.24K $12.46M Reduce
Q3 2024 669.49K $2.17M New
Q4 2024 148.63K $561.81K Reduce
Q1 2025 187.31K $663.08K Add
Q2 2025 275.84K $1.77M Add
Q3 2025 327.31K $4.45M Add
Q4 2025 317.68K $3.84M Reduce
Q1 2026 142.34K $1.98M Reduce
Q2 2026 155.42K $2.79M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMLX and 13F data

AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 51 other funds we track also report a position in AMLX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$149.7M), TCG Crossover Management, LLC (US$112.1M), Commodore Capital LP (US$101.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMLX

All AMLX fund holders →

FAQ

How long has Alpha Wave Global, LP held AMLX?

Alpha Wave Global, LP has disclosed AMLX holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

What is Alpha Wave Global, LP's current position in AMLX?

As of Q2 2026, Alpha Wave Global, LP holds 155.42K shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $2.79M, representing 0.04% of its reported portfolio and ranking #20.

Has Alpha Wave Global, LP been buying or selling AMLX?

In the latest 13F filing (Q2 2026), Alpha Wave Global, LP increased its position in AMLX.

Which other funds hold AMLX?

Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, Commodore Capital LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.